Page last updated: 2024-12-05

propoxur

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Propoxur: A carbamate insecticide. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

propoxur : A carbamate ester that is phenyl methylcarbamate substituted at position 2 by a propan-2-yloxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID4944
CHEMBL ID446060
CHEBI ID34938
SCHEMBL ID27794
MeSH IDM0361417

Synonyms (147)

Synonym
smr000778062
BIDD:ER0307
MLS002207242
DIVK1C_006650
2-[(1-methylethyl)oxy]phenyl methylcarbamate
propoksuru [polish]
o-impc
ipmc
mrowkozol
o-(2-isopropoxyphenyl) n-methylcarbamate
caswell no. 508
propoxure
unden 50pm
nsc 379584
ent 25,671
suncide
oms-33
boruho 50
brygou
o-isopropoxyphenyl n-methylcarbamate
2-isopropoxyphenyl-n-methylcarbamat [german]
hsdb 603
bay 9010
blattanex
bay 39007
bolfo
phc (carbamate)
phc 7
epa pesticide chemical code 047802
einecs 204-043-8
propyon
boruho
propoxylor
bifex
isocarb
bayer 39007
o-isopropoxyphenyl methylcarbamate
ccris 1392
propotox
rhoden
bayer b 5122
dalf dust
brn 1879891
phenol, o-isopropoxy-, methylcarbamate
ai3-25671
tugon fliegenkugel
sendran
invisi-gard
unden (pesticide)
chemagro 9010
2-(1-methylethoxy)phenol methylcarbamate
bay 5122
blattosep
2-isopropoxyphenyl methylcarbamate
2-isopropoxyphenyl n-methylcarbamate
propoxur
2-(propan-2-yloxy)phenyl methylcarbamate
aprocarb
CHEBI:34938 ,
2-(1-methylethoxy)phenyl methylcarbamate
SPECTRUM_001923
carbamic acid, methyl-, o-isopropoxyphenyl ester
phenol, 2-(1-methylethoxy)-, methylcarbamate
BSPBIO_002473
SPECTRUM5_002032
nsc379584
nsc-379584
114-26-1
baygon
PHC ,
2-isopropoxyphenyl-n-methylcarbamate
NCGC00094544-02
NCGC00094544-01
NCGC00094544-03
KBIO3_001973
KBIO1_001594
KBIO2_007594
KBIO2_002458
KBIO2_005026
KBIOGR_001193
KBIOSS_002465
SPECTRUM2_001232
SPECTRUM4_000697
SPBIO_001104
SPECPLUS_000554
SPECTRUM3_000857
SPECTRUM330066
NCGC00094544-04
NCGC00094544-05
isopropoxyphenyl methylcarbamate
propoxur (ban)
bolfo (tn)
D08442
CHEMBL446060
inchi=1/c11h15no3/c1-8(2)14-9-6-4-5-7-10(9)15-11(13)12-3/h4-8h,1-3h3,(h,12,13)
isrugxgccgioqo-uhfffaoysa-
(2-propan-2-yloxyphenyl) n-methylcarbamate
NCGC00094544-06
NCGC00094544-07
HMS3264G19
dtxsid7021948 ,
NCGC00255104-01
cas-114-26-1
dtxcid301948
tox21_301207
NCGC00259517-01
tox21_201968
pharmakon1600-00330066
nsc-755890
nsc755890
CCG-39115
propoxur [inn:ban]
propoksuru
unii-bfh029tl73
2-isopropoxyphenyl-n-methylcarbamat
arprocarb
bfh029tl73 ,
oms 33
2-(1-methylethoxy)phenyl n-methylcarbamate
FT-0603314
AKOS015889907
SCHEMBL27794
propoxur [mi]
propoxur [hsdb]
propoxur [jan]
propoxur [mart.]
boygon
2-(1-methylethoxy)phenyl methyl carbamate
carbamic acid, methyl-, 2-(1-methylethoxy)phenyl ester
propogon
n-methyl-2-isopropoxyphenylcarbamate
pillargon
phenol, 2-(1-methylethoxy)-, 1-(n-methylcarbamate)
HY-B0916
AB00053059_04
bdbm50064617
J-003071
sr-01000872751
SR-01000872751-1
propoxur, pestanal(r), analytical standard
SBI-0052551.P002
Q411303
AS-50078
O10810
mfcd00055455
2-methylethoxyphenyl carbamate
P2894

Research Excerpts

Overview

Propoxur is a carbamate insecticide widely used both in indoor and outdoor place to control insects. Propoxur induced urinary bladder cancer in Wistar rats when fed at 5000ppm in Altromin 1321 diet (1321)

ExcerptReferenceRelevance
"Propoxur is a carbamate insecticide widely used both in indoor and outdoor place to control insects. "( Propoxur (PPx) exposure as hormonal disruptor and spermatocidal in rat model.
Dare, BJ; Eweoya, GO; Oyewopo, AO, 2022
)
3.61
"Propoxur (PPX) is a carbamate insecticide which induced urinary bladder cancer in Wistar rats when fed at 5000ppm in Altromin 1321 diet (1321). "( The urinary bladder carcinogen propoxur does not produce genotoxic effects in the urinary bladder of Wistar male rats.
Duan, JD; Iatropoulos, MJ; Schmuck, G; Williams, GM, 2015
)
2.15
"Propoxur is a carbamate insecticide that has recently attracted considerable attention as a possible treatment option for addressing the bedbug epidemic. "( Propoxur: a novel mechanism for insecticidal action and toxicity.
Kovacic, P; Somanathan, R, 2012
)
3.26
"Propoxur is a widely used dithiocarbamate pesticide. "( Assessment of mutagenic potential of propoxur and its modulation by indole-3-carbinol.
Agrawal, RC; Mehrotra, Nk,
)
1.85
"Propoxur is a widely used dithiocarbamate insecticide. "( Induction of chromosomal aberrations by propoxur in mouse bone marrow cells.
Agrawal, RC, 1999
)
2.01

Effects

Propoxur has an ecotoxicological potential on fish, a nontarget organism. Propoxur, a carbamate, has been widely used for vector control.

ExcerptReferenceRelevance
"Propoxur has an ecotoxicological potential on fish, a nontarget organism."( Sublethal propoxur toxicity to juvenile common carp (Cyprinus carpio L., 1758): biochemical, hematological, histopathological, and genotoxicity effects.
Ayhan, A; Benli, AÇ; Cakiroğullari, GÇ; Erkoç, F; Gül, A; Memmi, BK; Selvi, M; Sepici-Dinçel, A, 2012
)
1.5
"Propoxur, a carbamate, has been widely used for vector control."( The overexpression and variant of CYP6G4 associated with propoxur resistance in the housefly, Musca domestica L.
Gao, X; Ma, Z; Shan, C; You, C; Zhang, Y; Zhao, R, 2021
)
1.59
"Propoxur has an ecotoxicological potential on fish, a nontarget organism."( Sublethal propoxur toxicity to juvenile common carp (Cyprinus carpio L., 1758): biochemical, hematological, histopathological, and genotoxicity effects.
Ayhan, A; Benli, AÇ; Cakiroğullari, GÇ; Erkoç, F; Gül, A; Memmi, BK; Selvi, M; Sepici-Dinçel, A, 2012
)
1.5

Actions

ExcerptReferenceRelevance
"Propoxur does not produce tumours in mice or hamsters, or bladder hyperplasia in dogs and monkeys following oral feeding."( Carcinogenicity and co-carcinogenicity studies on propoxur in mouse skin.
Baqar, SM; Mehrotra, NK; Shukla, Y, 1998
)
1.27

Treatment

ExcerptReferenceRelevance
"Propoxur-treated animals were also resistant to the hypothermic effect of an acute administration of the same compound."( Tolerance to the carbamate insecticide propoxur.
Costa, LG; Hand, H; Murphy, SD; Schwab, BW, 1981
)
1.25

Toxicity

Propoxur exerted obvious acute toxic effects on the survival, spontaneous movement, hatching and heart rate of zebrafish embryos. Because of the extensive use of aerosol propoxur, the adverse effect on cells of respiratory origin is worth elucidating.

ExcerptReferenceRelevance
" Because of the extensive use of aerosol propoxur, the adverse effect on cells of respiratory origin is worth elucidating."( Genotoxicity of propoxur and its N-nitroso derivative in mammalian cells.
Chang, YL; Chiou, JM; Hu, MC; Wang, TC, 1998
)
0.91
"Insecticides are important candidates for immunotoxicology tests in order to assess the 'No Observable Adverse Effect Level' (NOAEL)."( Evaluation of immunotoxicity induced by propoxure in C57Bl/6 mice.
Azizi, E; Hassan, ZM; Minaee, B; Narenjkar, J; Neishabouri, EZ; Ostad, SN, 2004
)
0.59
" Due to the fact that the stomach has been identified as the major target for N-nitroso N-methylcarbamates, this investigation used a human gastric cell line, SC-M1, in order to obtain results pertinent to the authentic adverse effects of this compound on human health."( Genotoxicity of low dose N-nitroso propoxur to human gastric cells.
Kuo, HH; Shyu, SS; Wang, TC, 2008
)
0.62
"To investigate possible joint toxic effects of diazinon, propoxur and bisphenol A (BPA) on proliferation of RAW264."( [Study of three methods on joint toxicity of diazinon, propoxur and bisphenol A on proliferation of mouse RAW264.7 cell].
Hao, W; Huang, J; Huang, Q; Li, N; Tan, X; Yang, X, 2011
)
0.86
" The types of toxic interaction of diazinon & BPA and propoxur & BPA were assessed by three methods commonly used for binary mixtures, which were Additional Index Method, Equivalent Effect Curve Method and Logistic Regression Method."( [Study of three methods on joint toxicity of diazinon, propoxur and bisphenol A on proliferation of mouse RAW264.7 cell].
Hao, W; Huang, J; Huang, Q; Li, N; Tan, X; Yang, X, 2011
)
0.87
" Propoxur exerted obvious acute toxic effects on the survival, spontaneous movement, hatching and heart rate, and development (yolk and pericardial sac edema) of zebrafish embryos in both time- and concentration-dependent manner only at ⩾ 100 μg/ml."( Evaluation of cytotoxicity, genotoxicity and embryotoxicity of insecticide propoxur using flounder gill (FG) cells and zebrafish embryos.
Guo, H; Pandey, MR, 2014
)
1.54

Compound-Compound Interactions

ExcerptReferenceRelevance
" In this study, female Wistar rats were given 1/25 LD50 of dimethoate by gavage, combined with the same LD50 fractions of propoxur and cypermethrin or with arsenic (6."( Changes in the central nervous activity of rats treated with dimethoate in combination with other neurotoxicants in different phases of ontogenesis.
Fazakas, Z; Lengyel, Z; Nagymajtényi, L, 2005
)
0.54

Dosage Studied

Propoxur dosing induced increased urinary taurine, creatinine and glucose. urinary lactate and acetate were increased in the highest permethrin dose group. Acetylcholinesterase activity of approximately 80% of both populations was not inhibited by a standard dosage of propoxur.

ExcerptRelevanceReference
" As dosage of these compounds increased, only small effects on accuracy were observed, followed at still larger doses by an abrupt and non-selective decrease in all responding."( Effects of pesticides and drugs on working memory in rats: continuous non-match.
Heise, GA; Hudson, JD, 1985
)
0.27
" Groups of mice were challenged with the cholinergic agonist carbachol at intervals during the drinking water dosing and at its end."( Tolerance to the carbamate insecticide propoxur.
Costa, LG; Hand, H; Murphy, SD; Schwab, BW, 1981
)
0.53
" Acetylcholinesterase activity of approximately 80% of both populations was not inhibited by a standard dosage of propoxur."( Insecticide cross-resistance spectra and underlying resistance mechanisms of Sri Lankan anopheline vectors of malaria.
Karunaratne, SH, 1999
)
0.51
" Dose-response models for the acute and repeated exposure data did not differ for brain ChE activity or the duration of the PhAD."( Cholinesterase inhibition and depression of the photic after discharge of flash evoked potentials following acute or repeated exposures to a mixture of carbaryl and propoxur.
Haber, L; Herr, DW; Hertzberg, RC; Kohrman-Vincent, M; Li, R; Lyke, DF; Lyles, RH; Macmillan, DK; Mwanza, JC; Pan, Y; Simmons, JE; Swank, AE; Zehr, RD, 2012
)
0.57
"Mixture risk assessment is often hampered by the lack of dose-response information on the mixture being assessed, forcing reliance on component formulas such as dose addition."( A four-step approach to evaluate mixtures for consistency with dose addition.
Haber, LT; Herr, DW; Hertzberg, RC; Li, R; Lyles, RH; Moser, VC; Pan, Y; Simmons, JE, 2013
)
0.39
"Propoxur dosing induced increased urinary taurine, creatinine and glucose, whereas urinary lactate and acetate were increased in the highest permethrin dose group."( Applying biofluid metabonomic techniques to analyze the combined subchronic toxicity of propoxur and permethrin in rats.
Liang, YJ; Long, DX; Wang, HP; Wu, YJ, 2012
)
2.04
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
carbamate insecticideDerivatives of carbamic acid with insecticidal properties of general formula ROC(=O)NR(1)R(2), where ROH is an alcohol, oxime, or phenol and R(1) is hydrogen or methyl. Like organophosphate insecticides, they are cholinesterase inhibitors, but carbamate insecticides differ in action from the organophosphates in that the inhibitory effect on cholinesterase is generally brief.
acaricideA substance used to destroy pests of the subclass Acari (mites and ticks).
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (14)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency7.23870.002541.796015,848.9004AID1347395; AID1347397; AID1347398; AID1347399
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.01090.006038.004119,952.5996AID1159521
TDP1 proteinHomo sapiens (human)Potency29.09290.000811.382244.6684AID686979
GLI family zinc finger 3Homo sapiens (human)Potency34.26190.000714.592883.7951AID1259369; AID1259392
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency31.62280.011212.4002100.0000AID1030
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency27.77080.001022.650876.6163AID1224838; AID1224839; AID1224893
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.00150.001530.607315,848.9004AID1224849
pregnane X nuclear receptorHomo sapiens (human)Potency48.60710.005428.02631,258.9301AID1346982
chromobox protein homolog 1Homo sapiens (human)Potency79.43280.006026.168889.1251AID540317
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency27.33380.000323.4451159.6830AID743065
gemininHomo sapiens (human)Potency2.31090.004611.374133.4983AID624296
Cellular tumor antigen p53Homo sapiens (human)Potency2.51190.002319.595674.0614AID651743
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)1.44500.00000.933210.0000AID1251506; AID1251507
AcetylcholinesteraseAnopheles gambiae (African malaria mosquito)IC50 (µMol)0.11280.04360.38210.9600AID1251508; AID1251510
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (138)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (43)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (31)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (58)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID671040Inhibition of human recombinant AChE after 6 mins by Ellman assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1251515Insecticidal activity against Anopheles gambiae G3 assessed as torsal contact toxicity by measuring mortality at 1000 ug/mL after 24 hrs by filter paper based method2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID379118Ratio of LT50 for Blattella germanica Muncie second instars to LT50 for Blattella germanica Jwax second instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID671042Toxicity in Anopheles gambiae G3 assessed as mortality treated as tarsal contact using dried filter papers after 24 hrs2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1422747Insecticidal activity against five day old female adult Aedes aegypti Mombasa assessed as mortality rate at 21 ng administered via micro-injection measured after 24 hrs relative to control2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Noncovalent Inhibitors of Mosquito Acetylcholinesterase 1 with Resistance-Breaking Potency.
AID1452691Insecticidal activity against 3rd instar larvae of Anopheles gambiae Kisumu assessed as mortality at 25 uM administered via de-chlorinated tap water after 48 hrs2017European journal of medicinal chemistry, Jul-07, Volume: 134N-Aryl-N'-ethyleneaminothioureas effectively inhibit acetylcholinesterase 1 from disease-transmitting mosquitoes.
AID379115Insecticidal activity against insecticide-resistant Blattella germanica Muncie second instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID671043Toxicity in anesthetized Anopheles gambiae G3 assessed as mortality treated as topical application assessed per mosquito after 24 hrs2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1251522Insecticidal activity against Anopheles gambiae G3 assessed as mortality after 24 hrs2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1422750Insecticidal activity against topically dosed female adult Aedes aegypti assessed as mortality measured after 24 hrs2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Noncovalent Inhibitors of Mosquito Acetylcholinesterase 1 with Resistance-Breaking Potency.
AID671041Selectivity ratio of Ki for Anopheles gambiae AChE to Ki for human recombinant AChE2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1251516Drug degradation assessed as evaporative weight loss after 1 day2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1192961Inhibition of recombinant wild-type Anopheles gambiae AChE compound incubated for up to 6 min at approximately 1 min interval2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1251507Inhibition of recombinant human AChE after 60 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1192962Inhibition of recombinant Anopheles gambiae AChE G119S mutant compound incubated for up to 60 mins at approximately 10 mins interval2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1251519Drug degradation assessed as evaporative weight loss after 28 days2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251511Inhibition of Anopheles gambiae AChE G119S mutant after 10 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1452698Insecticidal activity against five days old adult Anopheles gambiae Kisumu assessed as mortality at 6.25 ng applied topically on upper part of pronotum after 24 hrs2017European journal of medicinal chemistry, Jul-07, Volume: 134N-Aryl-N'-ethyleneaminothioureas effectively inhibit acetylcholinesterase 1 from disease-transmitting mosquitoes.
AID1251506Inhibition of recombinant human AChE after 10 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1192964Selectivity ratio of Ki for recombinant wild-type Anopheles gambiae AChE to Ki for recombinant Anopheles gambiae AChE G119S mutant2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID379116Insecticidal activity against insecticide-susceptible Blattella germanica Jwax fifth instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID1251514Insecticidal activity against Anopheles gambiae G3 assessed as torsal contact toxicity by measuring mortality after 24 hrs by filter paper based method2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID344083Insecticidal activity against houseflies2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Potency and selectivity of trifluoroacetylimino and pyrazinoylimino nicotinic insecticides and their fit at a unique binding site niche.
AID1192960Resistant ratio of LC50 for Anopheles gambiae Akron (MRA-913) to LC50 for Anopheles gambiae G3 (MRA-112)2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1251508Inhibition of recombinant Anopheles gambiae wild type AChE after 60 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID379119Ratio of LT50 for Blattella germanica Muncie fifth instars to LT50 for Blattella germanica Jwax fifth instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID1251520Insecticidal activity against Anopheles gambiae G3 assessed as fumigation mortality at 1000 ng/mL after 24 hrs by mason jar assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251523Insecticidal activity against Anopheles gambiae G3 assessed as mortality at 50 ng/insect after 24 hrs (Rvb = 11 +/- 4%)2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251510Inhibition of recombinant Anopheles gambiae wild type AChE after 10 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID671037Inhibition of Anopheles gambiae AChE2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1452692Insecticidal activity against 3rd instar larvae of Anopheles gambiae Kisumu assessed as mortality at 25 uM administered via de-chlorinated tap water after 24 hrs2017European journal of medicinal chemistry, Jul-07, Volume: 134N-Aryl-N'-ethyleneaminothioureas effectively inhibit acetylcholinesterase 1 from disease-transmitting mosquitoes.
AID1192957Tarsal contact toxicity in Anopheles gambiae Akron (MRA-913) assessed as mortality measured at 24 hrs by filter paper assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID671039Inhibition of Anopheles gambiae AChE expressed in Escherichia coli after 6 mins by Ellman assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1192955Tarsal contact toxicity in Anopheles gambiae G3 (MRA-112) assessed as mortality measured at 24 hrs by filter paper assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID379117Insecticidal activity against insecticide-resistant Blattella germanica Muncie fifth instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID1251509Inhibition of recombinant Anopheles gambiae AChE G119S mutant after 60 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251518Drug degradation assessed as evaporative weight loss after 12 days2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID379114Insecticidal activity against insecticide-susceptible Blattella germanica Jwax second instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID1251517Drug degradation assessed as evaporative weight loss after 6 days2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID468443Inhibition of human FAAH at 1 uM2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1192963Inhibition of recombinant human AChE2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1134599CHCl3-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (394)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990137 (34.77)18.7374
1990's74 (18.78)18.2507
2000's90 (22.84)29.6817
2010's82 (20.81)24.3611
2020's11 (2.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.86 (24.57)
Research Supply Index6.08 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index97.48 (26.88)
Search Engine Supply Index3.16 (0.95)

This Compound (39.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (0.93%)5.53%
Reviews6 (1.39%)6.00%
Case Studies13 (3.01%)4.05%
Observational0 (0.00%)0.25%
Other409 (94.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]